Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Techne

59.98
-1.0900-1.78%
Post-market: 59.980.00000.00%16:22 EDT
Volume:1.45M
Turnover:87.66M
Market Cap:9.48B
PE:61.22
High:61.86
Open:61.22
Low:59.33
Close:61.07
Loading ...

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
06 Mar

Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
05 Mar

Bio-Techne Ordered to Pay $35M in Stock Option Dispute

TIPRANKS
·
05 Mar

Bio-Techne Is Maintained at Neutral by Citigroup

Dow Jones
·
05 Mar

Abbott Laboratories (NYSE:ABT) Partners With Cadrenal Therapeutics For TECH-LVAD Trial In Growing US$2B LVAD Market

Simply Wall St.
·
05 Mar

TECH Joins Forces With Oxford Nanopore Technologies: Stock to Gain?

Zacks
·
04 Mar

Bio-Techne Corp : Citigroup Cuts Target Price to $70 From $80

THOMSON REUTERS
·
04 Mar

Citigroup Adjusts Price Target on Bio-Techne to $70 From $80, Maintains Neutral Rating

MT Newswires Live
·
04 Mar

Bio-Techne price target lowered to $70 from $80 at Citi

TIPRANKS
·
04 Mar

Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes

THOMSON REUTERS
·
03 Mar

Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes

PR Newswire
·
03 Mar

Press Release: SIMPLY SOLVENTLESS ANNOUNCES CLOSING OF HIGHLY ACCRETIVE DELTA 9 BIO-TECH ACQUISITION, DELTA 9 BIO-TECH NAME CHANGE TO HUMBLE GROW CO., AND OFFICER APPOINTMENT

Dow Jones
·
28 Feb

Weitz Partners III Opportunity Fund Added Bio-Techne Corporation (TECH) to its Portfolio

Insider Monkey
·
28 Feb

Argus Adjusts Price Target on Bio-Techne to $90 From $95

MT Newswires Live
·
27 Feb

Bio-Techne price target lowered to $90 from $95 at Argus

TIPRANKS
·
27 Feb

Bio-Techne to Present at Investor Conferences

PR Newswire
·
27 Feb